Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beryl L Manning-Geist

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|August 27, 2021
Diagnosis and management of an endometrial cancer patient with Cowden syndromeBeryl L Manning-Geist, Sonia Gatius, Ying Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 20, 2024
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
Gynecologic Oncology|January 13, 2019
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, et al.
Gynecologic Oncology Reports|February 16, 2022
Assessment of wound perfusion with near-infrared angiography: A prospective feasibility studyBeryl L Manning-Geist, Renee A Cowan, Brooke Schlappe, et al.
Gynecologic Oncology|September 21, 2020
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancerAlexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, et al.
American Journal of Obstetrics and Gynecology|May 15, 2019
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcomeBeryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2025
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancerBeryl L Manning-Geist, Madison Miller, Christian Dagher, et al.
Gynecologic Oncology|June 24, 2018
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
Annals of Surgical Oncology|March 8, 2021
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian CancerBeryl L Manning-Geist, Mackenzie W Sullivan, Vishnudas Sarda, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|August 27, 2021
Diagnosis and management of an endometrial cancer patient with Cowden syndromeBeryl L Manning-Geist, Sonia Gatius, Ying Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 20, 2024
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
Gynecologic Oncology|January 13, 2019
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, et al.
Gynecologic Oncology Reports|February 16, 2022
Assessment of wound perfusion with near-infrared angiography: A prospective feasibility studyBeryl L Manning-Geist, Renee A Cowan, Brooke Schlappe, et al.
Gynecologic Oncology|September 21, 2020
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancerAlexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, et al.
American Journal of Obstetrics and Gynecology|May 15, 2019
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcomeBeryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2025
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancerBeryl L Manning-Geist, Madison Miller, Christian Dagher, et al.
Gynecologic Oncology|June 24, 2018
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
Annals of Surgical Oncology|March 8, 2021
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian CancerBeryl L Manning-Geist, Mackenzie W Sullivan, Vishnudas Sarda, et al.
Pageof 4